Acurx Pharmaceuticals, Inc. (ACXP)
Largest Insider Buys in Sector
ACXP Stock Price History Chart
ACXP Stock Performance
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Insider Activity of Acurx Pharmaceuticals, Inc.
Over the last 12 months, insiders at Acurx Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Acurx Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Acurx Pharmaceuticals, Inc. have bought $149,611 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,161 shares for transaction amount of $24,979 was made by Sailer Carl (director) on 2021‑11‑23.
List of Insider Buy and Sell Transactions, Acurx Pharmaceuticals, Inc.
| 2021-11-23 | director | 5,161 0.0628% | $4.84 | $24,979 | -21.67% | |||
| 2021-11-19 | 5,034 0.0595% | $4.90 | $24,672 | -24.69% | ||||
| 2021-11-19 | President and CEO | 5,200 0.0602% | $4.80 | $24,960 | -24.69% | |||
| 2021-06-29 | director | 12,500 0.1719% | $6.00 | $75,000 | -30.67% |
Insider Historical Profitability
| DELUCCIA ROBERT J | 1031461 6.106% | $0.88 | 1 | 0 | <0.0001% | |
| LUCI DAVID P | President and CEO | 1008723 5.9714% | $0.88 | 1 | 0 | <0.0001% |
| Sailer Carl | director | 73078 0.4326% | $0.88 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $1.2M | 3.1 | 491,687 | +20.99% | +$208,984.97 | <0.0001 | |
| Geode Capital Management | $285,105.00 | 0.73 | 116,352 | +3.76% | +$10,340.55 | <0.0001 | |
| Advisor Group Holdings Inc | $140,262.00 | 0.36 | 57,250 | 0% | +$0 | <0.0001 | |
| State Street | $106,492.00 | 0.27 | 43,466 | +52.16% | +$36,505.10 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $98,576.00 | 0.25 | 40,235 | +194.12% | +$65,059.92 | <0.0001 | |
| Susquehanna International Group | $91,723.00 | 0.24 | 37,438 | -30.09% | -$39,481.71 | <0.0001 | |
| Morgan Stanley | $64,682.00 | 0.17 | 26,401 | +62.96% | +$24,989.83 | <0.0001 | |
| BlackRock | $45,786.00 | 0.12 | 18,688 | -70.4% | -$108,874.05 | <0.0001 | |
| Northern Trust | $42,025.00 | 0.11 | 17,153 | 0% | +$0 | <0.0001 | |
| Group One Trading | $33,028.00 | 0.09 | 13,481 | New | +$33,028.00 | <0.0001 | |
| Two Sigma | $31,816.00 | 0.08 | 12,986 | New | +$31,816.00 | <0.0001 | |
| Xtx Topco Ltd | $31,950.00 | 0.08 | 13,041 | New | +$31,950.00 | <0.01 | |
| Simplex Trading Llc | $26,000.00 | 0.07 | 10,729 | New | +$26,000.00 | <0.01 | |
| Patriot Financial Group Insurance Agency Llc | $25,443.00 | 0.07 | 10,385 | New | +$25,443.00 | <0.01 | |
| Tocqueville Asset Management | $24,500.00 | 0.06 | 10,000 | -23.66% | -$7,595.00 | <0.0001 | |
| Cambridge Investment Research Advisors Inc | $25,000.00 | 0.06 | 10,000 | New | +$25,000.00 | <0.0001 | |
| Semmax Financial Advisors Inc | $12,287.00 | 0.04 | 5,879 | 0% | +$0 | <0.01 | |
| Cornerstone Planning Group Llc | $7,257.00 | 0.02 | 3,344 | 0% | +$0 | <0.01 | |
| Tower Research Capital | $7,027.00 | 0.02 | 2,868 | New | +$7,027.00 | <0.0001 | |
| Cutler Group Lp | $2,000.00 | 0.01 | 1,200 | -47.83% | -$1,833.33 | <0.01 | |
| GPS Wealth Strategies Group LLC | $1,225.00 | <0.01 | 500 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $213.00 | <0.01 | 87 | +7.41% | +$14.69 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 37 | -30.19% | -$0 | <0.0001 |